The global antibody services market size is expected to reach USD 3.30 Billion in 2028 at a steady CAGR, according to latest analysis by Emergen Research. Some major factors driving market revenue growth are rising adoption of targeted immunotherapy, increasing focus on pharmaceutical and biological research, rising prevalence of infectious diseases, steady investment by government and private investors, and increasing demand for protein therapeutics. Antibody development is a process of characterization and generation of antibodies. Antibody purification services involve complete isolation of polyclinical bodies from serum or isolation of monoclonal antibodies from culture supernatant or ascites fluid. Scientists use antibody purification procedures to generate antibodies for biosensors to detect various infections.
Global Antibody Services Market research report delivers a comprehensive analysis of the market outlook, regulatory framework, and macro- and micro-economic factors influencing the growth of the market. The report is formulated through extensive research and surveys to offer accurate and authentic information about the market size, market share, product portfolio, revenue generation, and projected market growth. The report offers key insights into the competitive and regional landscape of the market to assist the stakeholders and investors in formulating strategic business plans.
Request For The Sample Copy @ https://www.emergenresearch.com/request-sample/632
Some Key Findings From the Report:
In February 2021, FairJourney Biologics and IONTAS introduced a protein sciences division, Flow Eighteen38. The new division will focus on the purification and characterization needs of a wide range of customers, starting from research institutions and start-ups, to biotechnology and biopharmaceutical organizations.
Antibody development segment is expected to register 11.5% revenue CAGR throughout the forecast period. This can be attributed to rising focus on drug discovery and biotechnological research activities.
Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period, which can be attributed to rapid advancements in pharmaceutical and healthcare infrastructure, rising number of biotech companies, and increasing investment by private investors in antibody development.
Key players operating in the market are GE Healthcare, Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, INTEGRA Biosciences AG, and FiberCell Systems Inc.
Key manufacturers and vendors are profiled extensively, including their product portfolios, production capacity, gross margins, revenues, and costing. The report also includes SWOT analysis, Porter’s Five Forces analysis, feasibility analysis, and investment return analysis. The report also provides profiles of key competitive players and their strategies and operating procedures. The report further provides insights into the opportunities and threats that the industry may witness in the upcoming years, throughout the forecast period.
The report also consists of an evaluation of key market trends, in-depth analysis of key segments and sub-market categorization on a regional and global scale.
For the purpose of this report, Emergen Research has segmented the global antibody services market based on service, type, end-use, and region:
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/antibody-services-market
The study further focuses on an in-depth analysis of the market growth in the key geographical regions of the world. The comprehensive study includes the following geographical regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The regions and their subsequent countries are analyzed for a detailed understanding of the market.
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a discount on the report @ https://www.emergenresearch.com/request-discount/632
Key points covered in the report:
A detailed outlook of the market with essential data beneficial for business
Market segmentation based on product types, applications, and end-users. For further understanding, the key segments are further divided into sub-segments
Growth factors, driving and restraining factors, product trends, and technological advancements are extensively discussed
Latest product developments, incorporation of new techniques and profiles of major competitors
An 8-year forecast estimation detailing the growth and expansion scope of the Antibody Services market
In-depth analysis of the historical years (2017-2018) and forecast period (2020-2027)
Market dynamics with information of players, challenges, restraints, threats, and opportunities
SWOT analysis and Porter’s Five Forces analysis of the top vendors
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/632
Table of Content
Chapter 1. Methodology & Sources
1.1. Antibody Services Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Antibody Services Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Antibody Services Market Segmentation & Impact Analysis
4.1. Antibody Services Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Antibody Services Market indicators analysis
4.2.2. Antibody Services Market drivers analysis
18.104.22.168. Rapid urbanization and industrialization
22.214.171.124. Stringent government regulations regarding carbon emissions
126.96.36.199. Increasing prevalence of respiratory diseases
188.8.131.52. Rising need to enhance indoor air quality
4.2.3. Antibody Services Market restraints analysis
184.108.40.206. High cost associated with the maintenance of Antibody Services products
220.127.116.11. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 10. Competitive Landscape
10.1. Antibody Services Market Revenue Share By Manufacturers
10.2. Mergers & Acquisitions
10.3. Competitor’s Positioning
10.4. Strategy Benchmarking
10.5. Vendor Landscape
10.5.1. Raw Material Suppliers
10.5.1.1. North America
10.5.1.3. Asia Pacific
10.5.1.4. Middle East & Africa
10.5.1.5. Latin America
10.5.2.1. North America
10.5.2.3. Asia Pacific
10.5.2.4. Middle East & Africa
10.5.2.5. Latin America
Thank you for reading our report. The report can be customized as per requirement. Please get in touch with us for further inquiries, and we will ensure you get the report best suited for your needs.